.png)
Vancouver’s AbCellera has acquired Trianni in an all-cash transaction valued at US $90 million. Trianni’s genetic engineering technology is a platform for developing humanized mice. The acquisition deepens AbCellera’s technology stack with a suite of genetically engineered mice for generating diverse panels of human antibodies with drug-like properties. “Trianni marks our fourth and largest strategic […]